Literature DB >> 27868048

Ground state naïve pluripotent stem cells and CRISPR/Cas9 gene correction for β-thalassemia.

Alessia Finotti1, Monica Borgatti1, Roberto Gambari2.   

Abstract

Entities:  

Year:  2016        PMID： 27868048      PMCID： PMC5104583          DOI： 10.21037/sci.2016.09.21

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN： 2306-9759


× No keyword cloud information.
  24 in total

1.  Generation of red blood cells from human induced pluripotent stem cells.

Authors:  Jessica Dias; Marina Gumenyuk; HyunJun Kang; Maxim Vodyanik; Junying Yu; James A Thomson; Igor I Slukvin
Journal:  Stem Cells Dev       Date:  2011-05-11       Impact factor: 3.272

2.  Law, history and lessons in the CRISPR patent conflict.

Authors:  Jacob S Sherkow
Journal:  Nat Biotechnol       Date:  2015-03       Impact factor: 54.908

3.  Factor-induced Reprogramming and Zinc Finger Nuclease-aided Gene Targeting Cause Different Genome Instability in β-Thalassemia Induced Pluripotent Stem Cells (iPSCs).

Authors:  Ning Ma; Yongli Shan; Baojian Liao; Guanyi Kong; Cheng Wang; Ke Huang; Hui Zhang; Xiujuan Cai; Shubin Chen; Duanqing Pei; Nansheng Chen; Guangjin Pan
Journal:  J Biol Chem       Date:  2015-03-20       Impact factor: 5.157

4.  Multicolor staining of globin subtypes reveals impaired globin switching during erythropoiesis in human pluripotent stem cells.

Authors:  Kiyosumi Ochi; Naoya Takayama; Shoichi Hirose; Tatsutoshi Nakahata; Hiromitsu Nakauchi; Koji Eto
Journal:  Stem Cells Transl Med       Date:  2014-05-29       Impact factor: 6.940

5.  Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases.

Authors:  Lin Ye; Judy C Chang; Chin Lin; Xiaofang Sun; Jingwei Yu; Yuet Wai Kan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-29       Impact factor: 11.205

6.  Naïve Induced Pluripotent Stem Cells Generated From β-Thalassemia Fibroblasts Allow Efficient Gene Correction With CRISPR/Cas9.

Authors:  Yuanyuan Yang; Xiaobai Zhang; Li Yi; Zhenzhen Hou; Jiayu Chen; Xiaochen Kou; Yanhong Zhao; Hong Wang; Xiao-Fang Sun; Cizhong Jiang; Yixuan Wang; Shaorong Gao
Journal:  Stem Cells Transl Med       Date:  2015-12-16       Impact factor: 6.940

7.  Gene therapy in thalassemia and hemoglobinopathies.

Authors:  Laura Breda; Roberto Gambari; Stefano Rivella
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-11-13       Impact factor: 2.576

Review 8.  Recent trends in the gene therapy of β-thalassemia.

Authors:  Alessia Finotti; Laura Breda; Carsten W Lederer; Nicoletta Bianchi; Cristina Zuccato; Marina Kleanthous; Stefano Rivella; Roberto Gambari
Journal:  J Blood Med       Date:  2015-02-19

9.  Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs.

Authors:  Peng Xu; Ying Tong; Xiu-zhen Liu; Ting-ting Wang; Li Cheng; Bo-yu Wang; Xiang Lv; Yue Huang; De-pei Liu
Journal:  Sci Rep       Date:  2015-07-09       Impact factor: 4.379

10.  Systematic identification of culture conditions for induction and maintenance of naive human pluripotency.

Authors:  Thorold W Theunissen; Benjamin E Powell; Haoyi Wang; Maya Mitalipova; Dina A Faddah; Jessica Reddy; Zi Peng Fan; Dorothea Maetzel; Kibibi Ganz; Linyu Shi; Tenzin Lungjangwa; Sumeth Imsoonthornruksa; Yonatan Stelzer; Sudharshan Rangarajan; Ana D'Alessio; Jianming Zhang; Qing Gao; Meelad M Dawlaty; Richard A Young; Nathanael S Gray; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2014-07-24       Impact factor: 24.633
View more
  2 in total

Review 1.  Applications of CRISPR/Cas9 in retinal degenerative diseases.

Authors:  Ying-Qian Peng; Luo-Sheng Tang; Shigeo Yoshida; Ye-Di Zhou
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

Review 2.  Emerging Therapies.

Authors:  Amaliris Guerra; Khaled M Musallam; Ali T Taher; Stefano Rivella
Journal:  Hematol Oncol Clin North Am       Date:  2017-12-15       Impact factor: 3.722
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.